GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3001 - 3025 of 4050 in total
Antibody Patient Onset (days) ▲ Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgG Patient 2 3 mild
G17689EW
48
IgG Patient 2 3 mild
G18057VI
601
IgG Patient 2 3 mild
G19118WX
23027
IgG Patient 2 3 mild
G19868AX
41
IgG Patient 2 3 mild
G21290RB
1432
IgG Patient 2 3 mild
G21320TF
446
IgG Patient 2 3 mild
G21460SG
607
IgG Patient 2 3 mild
G21675ZL
1378
IgG Patient 2 3 mild
G22768VO
122
IgG Patient 2 3 mild
G24432YB
24
IgG Patient 2 3 mild
G24617OK
78
IgG Patient 2 3 mild
G25407RZ
57
IgG Patient 2 3 mild
G25473LQ
43
IgG Patient 2 3 mild
G25559RS
1635
IgG Patient 2 3 mild
G26125KY
26641
IgG Patient 2 3 mild
G26295XE
2574
IgG Patient 2 3 mild
G27689OB
2008
IgG Patient 2 3 mild
G28868ZC
25
IgG Patient 2 3 mild
G29011JC
62
IgG Patient 2 3 mild
G29857RC
46
IgG Patient 2 3 mild
G30839DN
628
IgG Patient 2 3 mild
G31265MS
1728
IgG Patient 2 3 mild
G32473MI
11348
IgG Patient 2 3 mild
G32611KT
29
IgG Patient 2 3 mild
G32699RJ
47

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024